Stem Cell Banking Market by Cell Type, Bank Type, Service Type, and Utilization - Global Opportunity Analysis and Industry Forecast, 2017-2023

  • ID: 4580637
  • Report
  • Region: Global
  • 225 pages
  • Allied Analytics LLP
1 of 4
The global stem cell banking market was valued at $1,986 million in 2016, and is estimated to reach $6,956 million by 2023, registering a CAGR of 19.5% from 2017 to 2023. Stem cell banking is a process where the stem cell care isolated from different sources such as umbilical cord and bone marrow that is stored and preserved for future use. These cells can be cryo-frozen and stored for decades. Private and public banks are different types of banks available to store stem cells.

Increase in R&D activities in regards with applications of stem cells and increase in prevalence of fatal chronic diseases majorly drive the growth of the global stem cell banking market. Moreover, the large number of births occurring globally and growth in GDP & disposable income help increase the number of stem cell units stored, which would help fuel the market growth. However, legal and ethical issues related to stem cell collections and high processing & storage cost are projected to hamper the market growth. The initiative taken by organizations and companies to spread awareness in regards with the benefits of stem cells and untapped market in the developing regions help to open new avenues for the growth of stem cell banking market in the near future.

The global stem cell banking market is segmented based on cell type, bank type, service type, utilization, and region. Based on cell type, the market is classified into umbilical cord stem cells, adult stem cells, and embryonic stem cells. Depending on bank type, it is bifurcated into public and private. By service type, it is categorized into collection & transportation, processing, analysis, and storage. By utilization, it is classified into used and unused. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY MARKET BENEFITS
  • This report offers a detailed quantitative analysis of the current market trends from 2016 to 2023 to identify the prevailing opportunities.
  • The market estimations provided in this report are based on comprehensive analysis of the key developments in the industry.
  • In-depth analysis based on geography facilitates in analyzing the regional market to assist in strategic business planning.
  • The development strategies adopted by key manufacturers are enlisted in the report to understand the competitive scenario of the market.
KEY MARKET SEGMENTS

By Cell Type
  • Umbilical Cord Stem Cell
  • Cord Blood
  • Cord Tissue
  • Placenta
  • Adult Stem Cell
  • Embryonic Stem Cell
By Bank Type
  • Public
  • Private
By Service Type
  • Collection & Transportation
  • Processing
  • Analysis
  • Storage
By Utilization
  • Used
  • Unused
By Region
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Singapore
  • India
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA
KEY PLAYERS PROFILED
  • Cord Blood Registry
  • ViaCord
  • Cryo-Cell
  • China Cord Blood Corporation
  • Cryo-Save
  • New York Cord Blood Program
  • CordVida
  • Americord
  • CryoHoldco
  • Vita34
READ MORE
Note: Product cover images may vary from those shown
2 of 4
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Porters five forces analysis
3.4. Top Player Positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Large number of newborns
3.5.1.2. Increase in R&D activities for application of stem cells
3.5.1.3. Increase in prevalence of fatal chronic diseases
3.5.1.4. Growth in GDP and disposable income
3.5.2. Restraints
3.5.2.1. Legal and ethical issues during collection of stem cells
3.5.2.2. High processing and storage cost
3.5.2.3. Lack of acceptance and awareness
3.5.3. Opportunities
3.5.3.1. Initiatives to spread awareness
3.5.3.2. Untapped market in developing regions

CHAPTER 4: STEM CELL BANKING MARKET, BY CELL TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Umbilical Cord Stem Cells
4.2.1. Key market trends and growth opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country
4.2.4. Cord Blood
4.2.4.1. Market size and forecast
4.2.5. Cord Tissue
4.2.5.1. Market size and forecast
4.2.6. Placenta
4.2.6.1. Market size and forecast
4.3. Adult stem cells
4.3.1. Key market trends and growth opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country
4.4. Embryonic stem cells
4.4.1. Key market trends and opportunities
4.4.2. Market size and forecast
4.4.3. Market analysis, by country

CHAPTER 5: STEM CELL BANKING MARKET, BY BANK TYPE
5.1. Overview
5.1.1. Market size and forecast
5.2. Public
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.3. Private
5.3.1. Market size and forecast
5.3.2. Market analysis, by country

CHAPTER 6: STEM CELL BANKING MARKET, BY SERVICE TYPE
6.1. Overview
6.1.1. Market size and forecast
6.2. Collection and Transportation
6.2.1. Market size and forecast
6.2.2. Market analysis, by country
6.3. Processing
6.3.1. Market size and forecast
6.3.2. Market analysis, by country
6.4. Analysis
6.4.1. Market size and forecast
6.4.2. Market analysis, by country
6.5. Storage
6.5.1. Market size and forecast
6.5.2. Market analysis, by country

CHAPTER 7: STEM CELL BANKING MARKET, BY UTILIZATION
7.1. Overview
7.1.1. Market size and forecast
7.2. Used
7.2.1. Market size and forecast
7.2.2. Market analysis, by country
7.3. Unused
7.3.1. Market size and forecast
7.3.2. Market analysis, by country

CHAPTER 8: STEM CELL BANKING MARKET, BY REGION
8.1. Overview
8.1.1. Market size and forecast
8.2. North America
8.2.1. Key market trends and opportunities
8.2.2. Market size and forecast, by cell type
8.2.3. Market size and forecast, by bank type
8.2.4. Market size and forecast, by service type
8.2.5. Market size and forecast, by utilization
8.2.6. Market size and forecast, by country
8.2.6.1. U.S. Market size and forecast, by cell type
8.2.7. Market size and forecast, by bank type
8.2.7.1. U.S. Market size and forecast, by service type
8.2.7.2. U.S. Market size and forecast, by utilization
8.2.7.3. Canada Market size and forecast, by cell type
8.2.7.4. Market size and forecast, by bank type
8.2.7.5. Canada Market size and forecast, by service type
8.2.7.6. Canada Market size and forecast, by utilization
8.2.7.7. Mexico Market size and forecast, by cell type
8.2.7.8. Market size and forecast, by bank type
8.2.7.9. Mexico Market size and forecast, by service type
8.2.7.10. Mexico Market size and forecast, by utilization
8.3. Europe
8.3.1. Key market trends and opportunities
8.3.2. Market size and forecast, by cell type
8.3.3. Market size and forecast, by bank type
8.3.4. Market size and forecast, by service type
8.3.5. Market size and forecast, by utilization
8.3.6. Market size and forecast, by country
8.3.6.1. Germany Market size and forecast, by cell type
8.3.6.2. Market size and forecast, by bank type
8.3.6.3. Germany Market size and forecast, by service type
8.3.6.4. Germany Market size and forecast, by utilization
8.3.6.5. France Market size and forecast, by cell type
8.3.6.6. Market size and forecast, by bank type
8.3.6.7. France Market size and forecast, by service type
8.3.6.8. France Market size and forecast, by utilization
8.3.6.9. UK Market size and forecast, by cell type
8.3.6.10. UK Market size and forecast, by bank type
8.3.6.11. UK Market size and forecast, by service type
8.3.6.12. UK Market size and forecast, by utilization
8.3.6.13. Italy Market size and forecast, by cell type
8.3.6.14. Italy Market size and forecast, by bank type
8.3.6.15. Italy Market size and forecast, by service type
8.3.6.16. Italy Market size and forecast, by utilization
8.3.6.17. Spain Market size and forecast, by cell type
8.3.6.18. Spain Market size and forecast, by bank type
8.3.6.19. Spain Market size and forecast, by service type
8.3.6.20. Spain Market size and forecast, by utilization
8.3.6.21. Rest of Europe Market size and forecast, by cell type
8.3.6.22. Rest of Europe Market size and forecast, by bank type
8.3.6.23. Rest of Europe Market size and forecast, by service type
8.3.6.24. Rest of Europe Market size and forecast, by utilization
8.4. Asia-Pacific
8.4.1. Key market trends and opportunities
8.4.2. Market size and forecast, by cell type
8.4.3. Asia-Pacific Market size and forecast, by bank type
8.4.4. Market size and forecast, by service type
8.4.5. Market size and forecast, by utilization
8.4.6. Market size and forecast, by country
8.4.6.1. Japan Market size and forecast, by cell type
8.4.6.2. Japan Market size and forecast, by bank type
8.4.6.3. Japan Market size and forecast, by service type
8.4.6.4. Japan Market size and forecast, by utilization
8.4.6.5. China Market size and forecast, by cell type
8.4.6.6. China Market size and forecast, by bank type
8.4.6.7. China Market size and forecast, by service type
8.4.6.8. China Market size and forecast, by utilization
8.4.6.9. Singapore Market size and forecast, by cell type
8.4.6.10. Singapore Market size and forecast, by bank type
8.4.6.11. Singapore Market size and forecast, by service type
8.4.6.12. Singapore Market size and forecast, by utilization
8.4.6.13. India Market size and forecast, by cell type
8.4.6.14. India Market size and forecast, by bank type
8.4.6.15. India Market size and forecast, by service type
8.4.6.16. India Market size and forecast, by utilization
8.4.6.17. South Korea Market size and forecast, by cell type
8.4.6.18. South Korea Market size and forecast, by bank type
8.4.6.19. South Korea Market size and forecast, by service type
8.4.6.20. South Korea Market size and forecast, by utilization
8.4.6.21. Rest of Asia-Pacific Market size and forecast, by cell type
8.4.6.22. Rest of Asia-Pacific Market size and forecast, by bank type
8.4.6.23. Rest of Asia-Pacific Market size and forecast, by service type
8.4.6.24. Rest of Asia-Pacific Market size and forecast, by utilization
8.5. LAMEA
8.5.1. Key market trends and opportunities
8.5.2. Market size and forecast, by cell type
8.5.3. Market size and forecast, by bank type
8.5.4. Market size and forecast, by service type
8.5.5. Market size and forecast, by utilization
8.5.6. Market size and forecast, by country
8.5.6.1. Brazil Market size and forecast, by cell type
8.5.6.2. Brazil Market size and forecast, by bank type
8.5.6.3. Brazil Market size and forecast, by service type
8.5.6.4. Brazil Market size and forecast, by utilization
8.5.6.5. Saudi Arabia Market size and forecast, by cell type
8.5.6.6. Saudi Arabia Market size and forecast, by bank type
8.5.6.7. Saudi Arabia Market size and forecast, by service type
8.5.6.8. Saudi Arabia Market size and forecast, by utilization
8.5.6.9. South Africa Market size and forecast, by cell type
8.5.6.10. South Africa Market size and forecast, by bank type
8.5.6.11. South Africa Market size and forecast, by service type
8.5.6.12. South Africa Market size and forecast, by utilization
8.5.6.13. Rest of LAMEA Market size and forecast, by cell type
8.5.6.14. Rest of LAMEA Market size and forecast, by bank type
8.5.6.15. Rest of LAMEA Market size and forecast, by service type
8.5.6.16. Rest of LAMEA Market size and forecast, by utilization

CHAPTER 9: COMPANY PROFILES
9.1. Amag Pharmaceuticals, Inc.
9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Key strategic moves and developments
9.2. Americord Registry LLC
9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Key strategic moves and developments
9.3. China Cord Blood Corporation
9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Operating business segments
9.3.4. Key strategic moves and developments
9.4. Cord Blood America, Inc.
9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Key strategic moves and developments
9.5. Cordlife Group Limited
9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Business performance
9.5.5. Key strategic moves and developments
9.6. CordVida
9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Business performance
9.6.4. Key strategic moves and developments
9.7. Cryo-Cell International, Inc.
9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Key strategic moves and developments
9.8. Cryoholdco De LatinoAmerica, S.A.P.I. DE C.V.
9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Business performance
9.8.5. Key strategic moves and developments
9.9. ESPERITE N.V.
9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Business performance
9.9.5. Key strategic moves and developments
9.10. Lifeforce Cryobank Sciences, Inc.
9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Business performance
9.10.4. Key strategic moves and developments
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
According to a new report titled, Stem Cell Banking Market by Cell Type, Bank Type, Service Type, and Utilization: Global Opportunity Analysis and Industry Forecast, 2017-2023" the global stem cell banking market was valued at $1,986 million in 2016, and is estimated to reach $6,956 million by 2023, registering a CAGR of 19.5% from 2017 to 2023. North America is the highest contributor in the stem cell banking market in 2016; however, Asia-Pacific is expected to witness the highest growth rate during the forecast period.

Stem cells can repair and self-renewal damaged cells and can thus be used to treat various medical conditions. These cells are stored as they have the potential for usage in the treatment of any medical conditions that the person can further from in the future. The collected stem cells are cryopreserved and stored for decades, which can be later used to treat large number of chronic diseases such as leukemia, thalassemia, and diabetes.

Rise in number of births occurring globally, increase in R&D activities in regards with applications of stem cells, and surge in prevalence of fatal chronic diseases drive the growth of the market. The growth in GDP & disposable income globally is projected to help increase the number of stem cell units stored, which in turn boosts the market growth. However, legal and ethical issues related to stem cell collections and lack of acceptance and awareness in the developing regions are projected to hinder the market growth.

Among the cell type, the umbilical cord stem cell segment dominates the market, as these stem cells can be used to treat almost 80 diseases and the extraction process is easy and does to harm the newborn in any way. However, the adult stem cell segment is expected to register the highest growth rate during the forecast period.
Depending on bank type, the private stem cell banking is the dominant segment in the stem cell banking market. Although the number of public banks are more than private banks, the revenue generated by private stem cell banks are more, which contributes toward the growth of the market.

Key findings of the Stem Cell Banking Market:

Used stem cells is projected to grow at the highest rate among the utilization segment during the analysis period.
North America dominated global stem cell banking market in 2016, and is projected to continue its dominance in future.
China is expected to grow at the highest rate in the Asia-Pacific region during the forecast period.
Storage service segment was the largest contributor among the service type segments in 2016.
The private stem cell bank generated the highest revenue, and is expected to continue its dominance in future.

In 2016, North America was the major revenue contributor, owing to increase in awareness toward the benefits of storing stem cell and favorable regulatory scenario. However, Asia-Pacific is expected to witness the highest CAGR during the analysis period, due to high birth rate in populace countries such as India and China.

The key players operating in the global stem cell banking market include Cord Blood Registry, ViaCord, Cryo-Cell, China Cord Blood Corporation, Cryo-Save, New York Cord Blood Program, CordVida, Americord, CryoHoldco, and Vita34. Other prominent players in the value chain include Caladrius Biosciences, Cryoviva, Smart Cells International Ltd., Stemade Biotech, Cytori Therapeutics, Cellular Dynamics International, PerkinElmer, and Reelabs.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll